BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38684835)

  • 1. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids.
    Huang Y; Zhou S; Su Y; Pang Z; Cai S
    Sci Rep; 2024 Apr; 14(1):9857. PubMed ID: 38684835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids.
    Ikink ME; Voogt MJ; van den Bosch MA; Nijenhuis RJ; Keserci B; Kim YS; Vincken KL; Bartels LW
    Eur Radiol; 2014 Sep; 24(9):2118-27. PubMed ID: 24962829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MRI with deep learning for visualizing treatment results of MR-guided HIFU ablation of uterine fibroids.
    Slotman DJ; Bartels LW; Zijlstra A; Verpalen IM; van Osch JAC; Nijholt IM; Heijman E; van 't Veer-Ten Kate M; de Boer E; van den Hoed RD; Froeling M; Boomsma MF
    Eur Radiol; 2023 Jun; 33(6):4178-4188. PubMed ID: 36472702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-contrast enhanced MRI for assessment of uterine fibroids' early response to ultrasound-guided high-intensity focused ultrasound thermal ablation.
    Liao D; Xiao Z; Lv F; Chen J; Qiu L
    Eur J Radiol; 2020 Jan; 122():108670. PubMed ID: 31778966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of contrast-enhanced ultrasonography in MR-guided focused ultrasound ablation on uterus fibroids: lesion selection and assessment of ablative effects.
    Luo W; Zhang PD; Yang X; Zheng JM; Liu Y; Tang X; Liu HJ; Ding L; Pang LN; Zhou XD; Liu LW; Zheng MW
    Eur Radiol; 2022 Mar; 32(3):2110-2119. PubMed ID: 34751794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids.
    Peng S; Hu L; Chen W; Chen J; Yang C; Wang X; Zhang R; Wang Z; Zhang L
    Ultrasonics; 2015 Apr; 58():123-8. PubMed ID: 25627929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaled signal intensity of uterine fibroids based on T2-weighted MR images: a potential objective method to determine the suitability for magnetic resonance-guided focused ultrasound surgery of uterine fibroids.
    Park H; Yoon SW; Sokolov A
    Eur Radiol; 2015 Dec; 25(12):3455-8. PubMed ID: 25956935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffusion-weighted magnetic resonance imaging instead of contrast-enhanced imaging for evaluating immediate therapeutic efficacy of high-intensity focused ultrasound ablation of adenomyosis].
    Cui Y; Yao L; Feng M; Zhang J; Zhang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1583-1587. PubMed ID: 34755676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine fibroids: Influence of "T2-Rim sign" on immediate therapeutic responses to magnetic resonance imaging-guided high-intensity focused ultrasound ablation.
    Yeo SY; Kim YS; Lim HK; Rhim H; Jung SH; Hwang NY
    Eur J Radiol; 2017 Dec; 97():21-30. PubMed ID: 29153363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR Diffusion-Weighted Imaging in Evaluating Immediate HIFU Treatment Response of Uterine Fibroids.
    Cui Y; Zhang J; Rao J; Feng M; Yao L; Liao W; Liang C; Huang Y
    Curr Med Imaging; 2024 Feb; ():. PubMed ID: 38415459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance-guided high-intensity focused ultrasound of uterine fibroids: whole-tumor quantitative perfusion for prediction of immediate ablation response.
    Li C; Jin C; Liang T; Li X; Wang R; Zhang Y; Yang J
    Acta Radiol; 2020 Aug; 61(8):1125-1133. PubMed ID: 31779469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre.
    Mindjuk I; Trumm CG; Herzog P; Stahl R; Matzko M
    Eur Radiol; 2015 May; 25(5):1317-28. PubMed ID: 25510445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy.
    Voogt MJ; Trillaud H; Kim YS; Mali WP; Barkhausen J; Bartels LW; Deckers R; Frulio N; Rhim H; Lim HK; Eckey T; Nieminen HJ; Mougenot C; Keserci B; Soini J; Vaara T; Köhler MO; Sokka S; van den Bosch MA
    Eur Radiol; 2012 Feb; 22(2):411-7. PubMed ID: 21901565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes.
    Kim YS; Kim JH; Rhim H; Lim HK; Keserci B; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH
    Radiology; 2012 May; 263(2):600-9. PubMed ID: 22403170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography.
    Zhou XD; Ren XL; Zhang J; He GB; Zheng MJ; Tian X; Li L; Zhu T; Zhang M; Wang L; Luo W
    Eur J Radiol; 2007 May; 62(2):289-94. PubMed ID: 17258417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
    Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
    Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of single-dose gonadotropin-releasing hormone agonist administration prior to magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroids.
    Park H; Yoon SW
    Radiol Med; 2017 Aug; 122(8):611-616. PubMed ID: 28341966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids.
    Quinn SD; Vedelago J; Gedroyc W; Regan L
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():247-51. PubMed ID: 25445107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids.
    Kim YS; Kim TJ; Lim HK; Rhim H; Jung SH; Ahn JH; Lee JW; Kim BG
    Eur Radiol; 2017 Sep; 27(9):3956-3965. PubMed ID: 28210800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First experience of real-time elastography with transvaginal approach in assessing response to MRgFUS treatment of uterine fibroids.
    Marigliano C; Panzironi G; Molisso L; Pizzuto A; Ciolina F; Napoli A; Ricci P
    Radiol Med; 2016 Dec; 121(12):926-934. PubMed ID: 27586131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.